Hereditary spherocytosis medical therapy: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
No edit summary
Line 5: Line 5:
==Overview==
==Overview==
==Medical Therapy==
==Medical Therapy==
As in [[spherocytosis|non-hereditary spherocytosis]], acute symptoms of [[anemia]] and hyperbilirubinemia indicate treatment with [[blood transfusion]]s or exchanges and chronic symptoms of [[anemia]] and [[splenomegaly]] indicate dietary supplementation of [[iron]] and [[splenectomy]], the surgical removal of the [[spleen]].
Experimental [[gene therapy]] exists to treat hereditary spherocytosis in lab mice; however, this treatment has not yet been tried on humans and because of the risks involved in human gene therapy, it may never be.


==References==
==References==
Line 14: Line 11:
{{WH}}
{{WH}}
{{WS}}
{{WS}}


[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]

Revision as of 21:01, 20 February 2018